Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 9/2005

01-09-2005

CARD15/NOD2 Is Not a Predisposing Factor for Necrotizing Enterocolitis

Authors: Habib Zouali, Arnaud Bonnard, Pascal De Lagausie, Caroline Farnoux, Yves Aigrain, Jean-Pierre Cezard, Michel Peuchmaur, Jean-Pierre Hugot, Dominique Berrebi

Published in: Digestive Diseases and Sciences | Issue 9/2005

Login to get access
Metadata
Title
CARD15/NOD2 Is Not a Predisposing Factor for Necrotizing Enterocolitis
Authors
Habib Zouali
Arnaud Bonnard
Pascal De Lagausie
Caroline Farnoux
Yves Aigrain
Jean-Pierre Cezard
Michel Peuchmaur
Jean-Pierre Hugot
Dominique Berrebi
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Digestive Diseases and Sciences / Issue 9/2005
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-005-2915-z

Other articles of this Issue 9/2005

Digestive Diseases and Sciences 9/2005 Go to the issue

OriginalPaper

The Role of the Tumor Necrosis Factor Receptor in 2,4,6-Trinitrobenzene Sulfonic Acid (TNBS)-Induced Colitis in Mice

OriginalPaper

Acid Perfusion Test: A Useful Test for Evaluating Esophageal Acid Sensitivity

Case Report

Multiple Enterocolic Perforations and Their Possible Association with Prolonged Intake of Nimesulide: Report of Two Cases

OriginalPaper

Idiopathic Chronic Urticaria and Celiac Disease

OriginalPaper

Expression of Cytokeratins 7 and 20 in Serrated Adenoma and Related Diseases

OriginalPaper

The Relation Between NOD2/CARD15 Mutations and the Prevalence and Phenotypic Heterogeneity of Crohn’s Disease: Lessons from the Israeli Arab Crohn’s Disease Cohort
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits